abrdn Healthcare Investors

Research abrdn Healthcare Investors (HQH) on Bullrun: dividend yield 12.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

dividend yield is 12.9%.

Peer valuation comparison

Latest dividend yield is 12.91% versus a Financial Services sector median of 3.66% (253.2% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 99.81MUSD 98.61Mn/an/a1.61USD 59n/aUSD 1.09B
FY2024USD 186.46MUSD 184.95Mn/an/a3.53USD 56n/aUSD 1.06B
FY2023USD 58.12MUSD 56.33Mn/an/a1.09USD 214n/aUSD 931.34M
FY2022-USD 192.26M-USD 194.23Mn/an/a-1.04USD 792n/aUSD 916.56M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-12n/an/a12.5%2.47
20252025-12-31n/an/a11.6%2.19
20242024-12-31n/an/a14.2%2.28
20232023-12-29n/an/a9.7%1.6
20222022-12-30n/an/a9.5%1.71
20212021-12-31n/an/a8.6%2.04

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2.47 USD, yield 12.9%.

YearDividends/share
FY20252.19 USD
FY20242.28 USD
FY20231.6 USD
FY20221.71 USD

About abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies.

Related stock research

Other Financial Services stocks

Frequently asked questions

Does abrdn Healthcare Investors pay a dividend?

abrdn Healthcare Investors has a dividend yield of 12.9%.

What does abrdn Healthcare Investors do?

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies.